Safety and Dose Study of GRN163L Administered to Patients With Refractory or Relapsed Solid Tumor Malignancies
Clinical trial NCT00310895 · COMPLETED
Trial details
- NCT number
- NCT00310895
- Sponsor
- Geron Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2013-03-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.